COVAXX and Maersk enter partnership to supply COVID-19 vaccines globally
COVAXX, a U.S. company developing a multitope synthetic peptide-based vaccine to fight COVID-19, has announced a global logistics partnership with Maersk, one of the world’s largest shipping and integrated logistics providers. The agreement lays out a framework for all transportation and supply chain services that will be needed to deliver COVAXX’s vaccine candidate UB-612 […]
COVAXX and Maersk enter partnership to supply COVID-19 vaccines globally Read More »









